May 17, 2024 Q&A: Blood-based biomarker testing ‘scientific consensus favorite’ for AD detection read more
January 26, 2024 Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer’s Disease Pathology read more
October 3, 2023 Ultrasensitive immunoassay technology drives blood-based biomarkers for Alzheimer’s disease read more
September 6, 2023 Serum neurofilament light chain database effective in estimating pediatric neuro issues read more
July 18, 2023 Quanterix To Provide Research Use Access to the p217+tau Assay Through Quanterix Accelerator Services Laboratory read more
March 23, 2023 Accelerating Drug Approval with Simoa®: Ultrasensitive Measurement of Biomarkers read more
December 19, 2022 New Alzheimer’s Blood Tests May Be Game-Changers for Treating the Disease read more
October 3, 2022 Detecting neurological biomarkers in blood: How ultra-sensitive immunoassays are making CNS biomarker detection less invasive read more